Brain gadolinium deposition after administration of gadolinium-based contrast agents.
about
Effects of Gadolinium-Based Contrast Agents on Thyroid Hormone Receptor Action and Thyroid Hormone-Induced Cerebellar Purkinje Cell MorphogenesisCurrent and potential imaging applications of ferumoxytol for magnetic resonance imaging.Contribution of metals to brain MR signal intensity: review articles.The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review.Gadolinium retention in the body: what we know and what we can do.Status and trends in the development of clinical diagnostic agents.T1 Shortening in the Cerebral Cortex after Multiple Administrations of Gadolinium-based Contrast Agents.Lack of Contrast Enhancement in a Giant Perivascular Space of the Basal Ganglion on Delayed FLAIR Images: Implications for the Glymphatic System.Measurement of myocardial native T1 in cardiovascular diseases and norm in 1291 subjects.Cardiovascular CT for evaluation of single-ventricle heart disease: risks and accuracy compared with interventional findings.Gadolinium-based Contrast Media, Cerebrospinal Fluid and the Glymphatic System: Possible Mechanisms for the Deposition of Gadolinium in the Brain.Gadolinium retention after administration of contrast agents based on linear chelators and the recommendations of the European Medicines Agency.Distribution and chemical forms of gadolinium in the brain: a review.Development of High Signal Intensity within the Globus Pallidus and Dentate Nucleus following Multiple Administrations of Gadobenate Dimeglumine.Macrocyclic Gadolinium-Based Contrast Agents Do Not Cause Hyperintensity in the Dentate Nucleus.Longitudinal Assessment of Dentate Nuclei Relaxometry during Massive Gadobutrol Exposure.Gadolinium-Based Contrast Agent During Pelvic MRI: Contribution to Patient Management in Rectal Cancer.Diagnostic accuracy of low-dose dual-source cardiac computed tomography as compared to surgery in univentricular heart patients.
P2860
Q28828872-67278D97-6618-4122-9ED6-DC37BD77D520Q30234702-2408270E-244C-4118-B718-204B7F11F2C4Q31051153-D86344D6-F9D7-403E-B313-479767AB1501Q31161095-E04539FC-2920-4F91-AF90-C17A2BC0C790Q36329191-3E35B913-F3FB-47D0-848F-F5008C5F1510Q38995734-F29FF89F-7FBF-4AA6-93B7-0CD6BEF25432Q42359366-19325336-8150-4EE3-99A9-979FD9F5A1A4Q42359387-C65870C4-DB8F-4292-A616-16C903BA310CQ42365793-10F8090B-1DAD-4192-8B94-1C09DF77FCD8Q47254604-1CAF1CC8-3BCB-441C-A005-1FC6A91F42D4Q47701857-253E7B81-99BC-431B-8A7E-9DC671ED52E5Q48004031-896147A9-1607-4382-BCEE-AE0F6D2A58D3Q48177361-7DBCA6EC-BE3D-4CAB-8793-3AD923016774Q48216879-C0CE6FA0-C7A3-4C3A-A0FF-6DE11ECC0F80Q48229507-A901AF94-13B1-4C45-BBF9-3F49089D5FA2Q49388858-336DC4B5-F2E4-4A67-AC66-940BD7AEED88Q50103158-E6A679CC-3A33-4499-B510-EE14C6045EF4Q55402233-0778FF86-4E7A-42F5-A8B8-92DF31340663
P2860
Brain gadolinium deposition after administration of gadolinium-based contrast agents.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Brain gadolinium deposition after administration of gadolinium-based contrast agents.
@ast
Brain gadolinium deposition after administration of gadolinium-based contrast agents.
@en
type
label
Brain gadolinium deposition after administration of gadolinium-based contrast agents.
@ast
Brain gadolinium deposition after administration of gadolinium-based contrast agents.
@en
prefLabel
Brain gadolinium deposition after administration of gadolinium-based contrast agents.
@ast
Brain gadolinium deposition after administration of gadolinium-based contrast agents.
@en
P2093
P1476
Brain gadolinium deposition after administration of gadolinium-based contrast agents.
@en
P2093
Hiroshi Oba
Kazuhiro Kitajima
Keiko Toyoda
Shigeru Furui
Tomonori Kanda
P2888
P356
10.1007/S11604-015-0503-5
P577
2015-11-25T00:00:00Z